Levoleucovorin Calcium



Indications and Reactions:

Role Indications Reactions
Primary
Colorectal Cancer Metastatic 60.7%
Rectal Cancer 10.7%
Pelvic Venous Thrombosis 7.1%
Premedication 7.1%
Prophylaxis Of Nausea And Vomiting 7.1%
Vena Cava Thrombosis 7.1%
Anaemia Macrocytic 33.3%
Anaemia 16.7%
Candidiasis 16.7%
Shock 16.7%
Vomiting 16.7%
Secondary
Colorectal Cancer 30.9%
Colon Cancer Metastatic 11.1%
Colorectal Cancer Metastatic 8.1%
Large Intestine Carcinoma 7.2%
Prophylaxis 7.1%
Colon Cancer 5.6%
Rectal Cancer 5.5%
Hepatic Neoplasm Malignant 3.3%
Chemotherapy 3.1%
Prophylaxis Of Nausea And Vomiting 2.9%
Drug Use For Unknown Indication 2.0%
Hypertension 1.8%
Premedication 1.7%
Constipation 1.6%
Pain 1.4%
Prophylaxis Against Gastrointestinal Ulcer 1.4%
Rectal Cancer Recurrent 1.4%
Colon Cancer Recurrent 1.3%
Pancreatic Carcinoma 1.3%
Pelvic Venous Thrombosis 1.2%
Neutrophil Count Decreased 10.8%
Interstitial Lung Disease 8.5%
Neutropenia 7.7%
Anaemia 6.9%
Stomatitis 6.2%
Dermatitis Acneiform 5.4%
Febrile Neutropenia 5.4%
Decreased Appetite 4.6%
Drug Eruption 4.6%
Dehydration 3.8%
Diarrhoea 3.8%
Localised Intraabdominal Fluid Collection 3.8%
Nervous System Disorder 3.8%
Renal Failure Acute 3.8%
Thrombocytopenia 3.8%
Urinary Tract Infection 3.8%
White Blood Cell Count Decreased 3.8%
Anaemia Macrocytic 3.1%
Blepharitis 3.1%
Candidiasis 3.1%
Concomitant
Colorectal Cancer 34.3%
Prophylaxis 8.9%
Large Intestine Carcinoma 8.6%
Colon Cancer Metastatic 8.0%
Rectal Cancer Metastatic 6.8%
Colon Cancer 5.3%
Colon Cancer Recurrent 4.7%
Drug Use For Unknown Indication 4.4%
Rectal Cancer 3.9%
Rectal Cancer Recurrent 3.4%
Prophylaxis Of Nausea And Vomiting 2.3%
Premedication 1.8%
Hypertension 1.2%
Colorectal Cancer Metastatic 1.2%
Cancer Pain 1.1%
Chemotherapy 1.0%
Diabetes Mellitus 0.8%
Pain 0.8%
Constipation 0.8%
Gastric Ulcer 0.8%
Interstitial Lung Disease 25.8%
Stomatitis 6.3%
Dry Skin 5.9%
Dermatitis Acneiform 5.5%
Rash 5.5%
Colorectal Cancer 5.1%
Diarrhoea 4.7%
Hyperammonaemia 4.7%
Disease Progression 4.3%
Decreased Appetite 3.5%
Gastrointestinal Perforation 3.5%
Death 3.1%
Dyspnoea 3.1%
Leukoencephalopathy 3.1%
White Blood Cell Count Decreased 3.1%
Drug Hypersensitivity 2.7%
Ileus 2.7%
Malaise 2.7%
Congestive Cardiomyopathy 2.3%
Malignant Ascites 2.3%